United States - English - NLM (National Library of Medicine)

liebel-flarsheim company llc - ioversol (unii: n3rib7x24k) (ioversol - unii:n3rib7x24k) - ioversol 741 mg in 1 ml - optiray is indicated for: in adults - optiray 300: cerebral arteriography and peripheral arteriography. - optiray 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. - optiray 350: peripheral arteriography coronary arteriography, and left ventriculography. in pediatric patients - optiray 320 and optiray 350: angiocardiography. in adults - optiray 300: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 320: ct imaging of the head and body, venography, and intravenous excretory urography. - optiray 350: ct imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (iv-dsa). - in pediatric patients optiray 320: ct imaging of the head and body, and intravenous excretory urography. symptomatic hyperthyroidism risk summary postmarketing data with optiray use in pregnant women are insufficient to de

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the vardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections; trometamol hydrochloride; trometamol - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the cardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.

Australia - English - Department of Health (Therapeutic Goods Administration)

guerbet australia pty ltd - ioversol, quantity: 741 mg/ml (equivalent: iodine, qty 350 mg/ml) - injection, solution - excipient ingredients: trometamol hydrochloride; trometamol; sodium calcium edetate; sodium hydroxide; hydrochloric acid; water for injections - shelf life: other conditions: protect from secondary x-rays. optiray 350 is indicated in adults for angiography throughout the vardiovascular system by conventional or digital subtraction techniques. these include coronary, peripheral, visceral and renal arteriography, aortography, left ventriculography and venography. optiray may be used for intravenous excretary urography.